Bench Side to Bedside

Health sciences research activity at Rutgers is the largest and most comprehensive in New Jersey. In the life sciences alone, Rutgers expends more than $350 million annually in research and development. In 2015, Rutgers received $138.7 million in funding from the National Institutes of Health (NIH)—the nation’s medical research agency that supports vital discoveries that improve health and save lives. Our NIH funding is more than twice that of all other New Jersey NIH-funded universities combined.

What this means for patients is that our research spans the spectrum from “bench side” (innovative treatments developed in the laboratory) to “bedside” (direct care of people). Through research we

  • uncover the core processes of health sciences and health care;
  • test and develop clinical trials and other original interventions for patient care;
  • translate discoveries into innovations that advance health care and grow the economy;
  • better understand relationships among basic science, patient care, and society;
  • prepare future generations of scientists, practitioners, and policymakers.

Research at Our Schools, Centers, and Institutes

Schools

Many research activities within Rutgers Health are coordinated by the individual schools.

Primary Research Centers and Institutes

These primary research centers and institutes collaborate and work closely with Rutgers' biomedical and health schools.

Additional Research Centers and Institutes

Hundreds of additional centers, institutes, and other clinical entities as determined work collaboratively across disciplines with Rutgers Health units and with other institutions worldwide.

Behavioral Health Research

University Behavioral Health Care conducts behavioral health, mental health, and addiction research with the goal of offering cutting-edge technologies and new treatment alternatives.

Research Gateways

  • The Rutgers Clinical Research Organization (CRO) is the gateway to Rutgers' statewide clinical trial activities. Dedicated to effective collaboration between industry and academia to advance care and the boundaries of health care treatment, Rutgers partners with patients, industry, and practitioners to identify appropriate investigators and academic resources to meet patients’ needs.
  • Rutgers Translational Sciences (RTS) assists biomedical science faculty in creating and building interdisciplinary collaborative research. By providing access to facilities and expertise in molecular imaging, synthesis of probe molecules, and related technologies, RTS is committed to meeting the needs of both university and industry collaborators.
  • The Rutgers Office of Research and Economic Development works with Rutgers faculty and staff, major corporations and the region’s business community, and allies such as BioNJ and the New Jersey Business and Industry Association to make connections and foster collaborations for research and development initiatives across all of our campuses.
  • The Rutgers Office of Research Commercialization serves as a bridge between Rutgers researchers and commercialization partners, ensuring the smooth and fast transfer of intellectual property created at the university. The staff educates and serves as a resource for the Rutgers community on matters relating to intellectual property, technology commercialization, and entrepreneurship; protects intellectual property via trademarks and patents; and negotiates patent licenses.

Clinical Trials

Rutgers supports nearly 350 clinical trials at any given time, engaging thousands of patients and hundreds of researchers and clinicians in the search for better ways to treat or prevent diseases.